Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Clinical trial NCT02075047 · TERMINATED
Trial details
- NCT number
- NCT02075047
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-23
- Primary completion
- 2020-04-11
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.